Cargando…
Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964673/ https://www.ncbi.nlm.nih.gov/pubmed/35351868 http://dx.doi.org/10.1038/s41408-022-00644-2 |
_version_ | 1784678269403004928 |
---|---|
author | Huo, Yu-Jia Xu, Peng-Peng Fu, Di Yi, Hong-Mei Huang, Yao-Hui Wang, Li Wang, Nan Ji, Meng-Meng Liu, Qing-Xiao Shi, Qing Wang, Shuo Cheng, Shu Feng, Yan Zhao, Wei-Li |
author_facet | Huo, Yu-Jia Xu, Peng-Peng Fu, Di Yi, Hong-Mei Huang, Yao-Hui Wang, Li Wang, Nan Ji, Meng-Meng Liu, Qing-Xiao Shi, Qing Wang, Shuo Cheng, Shu Feng, Yan Zhao, Wei-Li |
author_sort | Huo, Yu-Jia |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-8964673 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-89646732022-04-12 Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication Huo, Yu-Jia Xu, Peng-Peng Fu, Di Yi, Hong-Mei Huang, Yao-Hui Wang, Li Wang, Nan Ji, Meng-Meng Liu, Qing-Xiao Shi, Qing Wang, Shuo Cheng, Shu Feng, Yan Zhao, Wei-Li Blood Cancer J Correspondence Nature Publishing Group UK 2022-03-29 /pmc/articles/PMC8964673/ /pubmed/35351868 http://dx.doi.org/10.1038/s41408-022-00644-2 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Correspondence Huo, Yu-Jia Xu, Peng-Peng Fu, Di Yi, Hong-Mei Huang, Yao-Hui Wang, Li Wang, Nan Ji, Meng-Meng Liu, Qing-Xiao Shi, Qing Wang, Shuo Cheng, Shu Feng, Yan Zhao, Wei-Li Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication |
title | Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication |
title_full | Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication |
title_fullStr | Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication |
title_full_unstemmed | Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication |
title_short | Molecular heterogeneity of CD30+ diffuse large B-cell lymphoma with prognostic significance and therapeutic implication |
title_sort | molecular heterogeneity of cd30+ diffuse large b-cell lymphoma with prognostic significance and therapeutic implication |
topic | Correspondence |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8964673/ https://www.ncbi.nlm.nih.gov/pubmed/35351868 http://dx.doi.org/10.1038/s41408-022-00644-2 |
work_keys_str_mv | AT huoyujia molecularheterogeneityofcd30diffuselargebcelllymphomawithprognosticsignificanceandtherapeuticimplication AT xupengpeng molecularheterogeneityofcd30diffuselargebcelllymphomawithprognosticsignificanceandtherapeuticimplication AT fudi molecularheterogeneityofcd30diffuselargebcelllymphomawithprognosticsignificanceandtherapeuticimplication AT yihongmei molecularheterogeneityofcd30diffuselargebcelllymphomawithprognosticsignificanceandtherapeuticimplication AT huangyaohui molecularheterogeneityofcd30diffuselargebcelllymphomawithprognosticsignificanceandtherapeuticimplication AT wangli molecularheterogeneityofcd30diffuselargebcelllymphomawithprognosticsignificanceandtherapeuticimplication AT wangnan molecularheterogeneityofcd30diffuselargebcelllymphomawithprognosticsignificanceandtherapeuticimplication AT jimengmeng molecularheterogeneityofcd30diffuselargebcelllymphomawithprognosticsignificanceandtherapeuticimplication AT liuqingxiao molecularheterogeneityofcd30diffuselargebcelllymphomawithprognosticsignificanceandtherapeuticimplication AT shiqing molecularheterogeneityofcd30diffuselargebcelllymphomawithprognosticsignificanceandtherapeuticimplication AT wangshuo molecularheterogeneityofcd30diffuselargebcelllymphomawithprognosticsignificanceandtherapeuticimplication AT chengshu molecularheterogeneityofcd30diffuselargebcelllymphomawithprognosticsignificanceandtherapeuticimplication AT fengyan molecularheterogeneityofcd30diffuselargebcelllymphomawithprognosticsignificanceandtherapeuticimplication AT zhaoweili molecularheterogeneityofcd30diffuselargebcelllymphomawithprognosticsignificanceandtherapeuticimplication |